circRNA basic information
circBase ID: hsa_circ_0085616
Name: -
Synonym: CircRNA_0085616
Host Gene: -
Genomic location(hg19): chr8:131370262-131374017:-
Genomic location(hg38): chr8:130358016-130361771:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0002974
MONDO name: cervical cancer
Disease details: cervical cancer
Disease DO ID:
4362
Disease MeSH ID:
-
Disease NCIt ID:
C9311
Disease ICD11 ID:
1256072522
Disease OMIM ID:
603956
Species: Human
Species details: Homo sapiens
Tissue specimen:

CC tissues; normal tissues

Cell lines:

HeLa; SiHa; C33A; CaSki; ECT1/E6E7

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: ATXN7L3
Associated microRNA: miR-503-5p
Biological function: circ_0085616 promotes cervical cancer cell proliferation, migration, invasion, glycolysis, and tumorigenesis in vivo.
Molecular mechanism: circ_0085616 acts as a miR-503-5p sponge to enhance ATXN7L3 expression, thereby promoting cervical cancer progression.
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); glycolysis (promotes); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Transfection; MTT; Colony Formation Assay; Transwell Assay; Western Blot; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); In Vivo Animal Model

Clinical significance:

circ_0085616 may be an effective target in the diagnosis and treatment of cervical cancer.

Description:

circ_0085616 is up-regulated in cervical cancer tissues and cell lines. It promotes proliferation, migration, invasion, glycolysis, and in vivo tumor growth by sponging miR-503-5p and activating ATXN7L3, suggesting potential diagnostic and therapeutic relevance.

Confidence score:

0.7045

Other information
Title:

Identification of circ_0085616 as an Upregulated and Oncogenic Circular RNA in Cervical Cancer Via the miR-503-5p-Mediated ATXN7L3 Activation.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: 2020
PubMed ID: 33090006
Study type:

combined biological and clinical study

Data availability: -
Code availability: -